Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter G Smith

Showing results (181-190 of 202) with videos related to

Pageof 21
Sort By:
Cancer Cell|March 24, 2012
Treatment-emergent mutations in NAEβ confer resistance to the NEDD8-activating enzyme inhibitor MLN4924Michael A Milhollen, Michael P Thomas, Usha Narayanan, et al.
BMJ Global Health|July 9, 2020
Ethical issues in intervention studies on the prevention and management of diabetes and hypertension in sub-Saharan AfricaElizabeth Shayo, Marie Claire Van Hout, Josephine Birungi, et al.
Cancer Cell|August 15, 2018
Synthetic Lethal and Convergent Biological Effects of Cancer-Associated Spliceosomal Gene MutationsStanley Chun-Wei Lee, Khrystyna North, Eunhee Kim, et al.
Cancer Cell|May 13, 2015
SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon RecognitionEunhee Kim, Janine O Ilagan, Yang Liang, et al.
Nature Communications|May 26, 2017
Splicing modulators act at the branch point adenosine binding pocket defined by the PHF5A-SF3b complexTeng Teng, Jennifer Hc Tsai, Xiaoling Puyang, et al.
Vaccine|January 25, 2020
Does respiratory syncytial virus lower respiratory illness in early life cause recurrent wheeze of early childhood and asthma? Critical review of the evidence and guidance for future studies from a World Health Organization-sponsored meetingAmanda J Driscoll, S Hasan Arshad, Louis Bont, et al.
Organic Letters|November 8, 2014
Total synthesis of 6-deoxypladienolide D and Assessment of Splicing Inhibitory Activity in a Mutant SF3B1 cancer cell lineKenzo Arai, Silvia Buonamici, Betty Chan, et al.
Cancer Research|December 17, 2017
H3B-6527 Is a Potent and Selective Inhibitor of FGFR4 in FGF19-Driven Hepatocellular CarcinomaJaya Julie Joshi, Heather Coffey, Erik Corcoran, et al.
Vaccine|April 27, 2017
Case-control vaccine effectiveness studies: Preparation, design, and enrollment of cases and controlsJennifer R Verani, Abdullah H Baqui, Claire V Broome, et al.
Vaccine|April 27, 2017
Case-control vaccine effectiveness studies: Data collection, analysis and reporting resultsJennifer R Verani, Abdullah H Baqui, Claire V Broome, et al.
Pageof 21

Showing results (181-190 of 202) with videos related to

Sort By:
Pageof 21
Cancer Cell|March 24, 2012
Treatment-emergent mutations in NAEβ confer resistance to the NEDD8-activating enzyme inhibitor MLN4924Michael A Milhollen, Michael P Thomas, Usha Narayanan, et al.
BMJ Global Health|July 9, 2020
Ethical issues in intervention studies on the prevention and management of diabetes and hypertension in sub-Saharan AfricaElizabeth Shayo, Marie Claire Van Hout, Josephine Birungi, et al.
Cancer Cell|August 15, 2018
Synthetic Lethal and Convergent Biological Effects of Cancer-Associated Spliceosomal Gene MutationsStanley Chun-Wei Lee, Khrystyna North, Eunhee Kim, et al.
Cancer Cell|May 13, 2015
SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon RecognitionEunhee Kim, Janine O Ilagan, Yang Liang, et al.
Nature Communications|May 26, 2017
Splicing modulators act at the branch point adenosine binding pocket defined by the PHF5A-SF3b complexTeng Teng, Jennifer Hc Tsai, Xiaoling Puyang, et al.
Vaccine|January 25, 2020
Does respiratory syncytial virus lower respiratory illness in early life cause recurrent wheeze of early childhood and asthma? Critical review of the evidence and guidance for future studies from a World Health Organization-sponsored meetingAmanda J Driscoll, S Hasan Arshad, Louis Bont, et al.
Organic Letters|November 8, 2014
Total synthesis of 6-deoxypladienolide D and Assessment of Splicing Inhibitory Activity in a Mutant SF3B1 cancer cell lineKenzo Arai, Silvia Buonamici, Betty Chan, et al.
Cancer Research|December 17, 2017
H3B-6527 Is a Potent and Selective Inhibitor of FGFR4 in FGF19-Driven Hepatocellular CarcinomaJaya Julie Joshi, Heather Coffey, Erik Corcoran, et al.
Vaccine|April 27, 2017
Case-control vaccine effectiveness studies: Preparation, design, and enrollment of cases and controlsJennifer R Verani, Abdullah H Baqui, Claire V Broome, et al.
Vaccine|April 27, 2017
Case-control vaccine effectiveness studies: Data collection, analysis and reporting resultsJennifer R Verani, Abdullah H Baqui, Claire V Broome, et al.
Pageof 21